Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure
- 1 April 1999
- journal article
- clinical trial
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 83 (8), 1201-1205
- https://doi.org/10.1016/s0002-9149(99)00059-4
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Comparative Hemodynamic, Left Ventricular Functional, and Antiadrenergic Effects of Chronic Treatment With Metoprolol Versus Carvedilol in the Failing HeartCirculation, 1996
- Carvedilol Produces Dose-Related Improvements in Left Ventricular Function and Survival in Subjects With Chronic Heart FailureCirculation, 1996
- Medical Therapy Can Improve the Biological Properties of the Chronically Failing HeartCirculation, 1996
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Bioenergetic Consequences of Left Ventricular RemodelingCirculation, 1995
- Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized studyJournal of the American College of Cardiology, 1995
- Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockadeJournal of the American College of Cardiology, 1995
- Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: A randomized, double-blind, placebo-controlled studyJournal of the American College of Cardiology, 1994
- Receptor Pharmacology of Carvedilol in the Human HeartJournal of Cardiovascular Pharmacology, 1992
- Canine left ventricular mass estimation by two-dimensional echocardiography.Circulation, 1983